BIIB stock has received mixed attention from the brokerage crowd this morning. UBS upgraded the shares to "neutral" from "sell," and bumped its price target up to $270 from $262, but Raymond James dropped its price target to $329 from …
Capital One National Association decreased its position in Biogen Inc. (NASDAQ:BIIB) by 3.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 23,476 shares of the biotechnology company’s …
Atlantic Trust Group Llc acquired 1,820 shares as Biogen Inc. (BIIB)’s stock declined 13.45%. The Atlantic Trust Group …
BIIB Stock Chart the entire biotech sector—surged in the wake of this result.In 2015, these business practices hit the limelight, and both presidential candidates vowed to crack down because business bottom lines are not as important as …
Biogen Inc. (NASDAQ:BIIB)’s stock on Monday traded at beginning with a price of $283.00 and when day-trade ended the stock finally gained 0.63% to reach at $284.70. Analyst’s mean target price for BIIB is $319.68 while analysts mean …
Biogen Inc (NASDAQ:BIIB) stock is getting whacked in sympathy to Eli Lilly and Co (NYSE:LLY)‘s announcement that it has once again failed in its quest to prove solanezumab to be a viable treatment for Alzheimer’s patients. While trading …
The Biogen Inc. (Nasdaq: BIIB) stock price was down about 6% this morning (Friday) after the company missed on Q1 earnings – but this slip won't last… Biogen reported earnings per share (EPS) of $3.82 compared to estimates of $3.91. …
Biogen Inc (NASDAQ: BIIB) stock lost over 1.1% on July 25 th, 2017 (as of 11:30AM EDT; Source: Google finance) as the group reported mixed performance in the second quarter of 2017. Total Interferon revenues lost 5% to $691 million in the …
Investors in Biogen Idec Inc (NASD: BIIB) saw new options begin trading today, for the May 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options chain for the new May 1st contracts …
Kazazian Asset Management Llc acquired 5,500 shares as Biogen Inc (BIIB)'s stock declined 13.45%. Despite rising competition, the company has maintained its global market share in the segment in the second-quarter. ICICI …